Nicholas Hill, MD oversees pulmonary hypertension clinics in Boston and in Providence at Rhode Island Hospital. He has a long-standing interest in the mechanisms of pulmonary hypertension and has performed basic research funded by the National Institutes of Health and the American Heart Association.
In addition, he has participated in numerous multi-center clinical trials on pulmonary hypertension, including those on epoprostenol for PPH and pulmonary arterial hypertension related to connective tissue disease, bosentan, treprostinil, sitaxsentan and ambrisentan. He has written extensively on clinical and basic aspects of pulmonary hypertension. Hill also has a clinical interest in mechanical ventilation, particularly noninvasive ventilation. He has performed numerous clinical studies and written extensively on this topic as well.
Hill is the immediate post-chair of the program committee of the critical care assembly of the American Thoracic Society. He holds a Distinguished Scholar Award from the American College of Chest Physicians. He is an associate editor of the journal Chest and serves on the editorial board of the American Journal of Respiratory and Critical Care Medicine.
More about Nicholas Hill, MD